Energetics in colorectal and prostate cancer

Journal of Clinical Oncology

Volumn 28, Issue 26, 2010, Pages 4066-4073

  Meyerhardt, Jeffrey A ^a   Ma, Jing ^a   Courneya, Kerry S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; DIET; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENERGY BALANCE; ENERGY TRANSFER; HUMAN; IMMOBILIZATION; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; WEIGHT CHANGE; BODY WEIGHT; COLORECTAL TUMOR; DISEASE COURSE; ENERGY METABOLISM; EXERCISE; MALE; METABOLISM; PROSTATE TUMOR;

ADIPOSITY; BODY MASS INDEX; BODY WEIGHT; COLORECTAL NEOPLASMS; DIET; DISEASE PROGRESSION; ENERGY METABOLISM; EXERCISE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 77956923841     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.8797     Document Type: Review

References (83)

1. Brown J, Byers T, Thompson K, et al: Nutrition during and after cancer treatment: A guide for informed choices by cancer survivors. CA Cancer J Clin 51:153-187, 2001 (Pubitemid 32479565)
2. Brown JK, Byers T, Doyle C, et al: Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin 53:268-291, 2003
3. Doyle C, Kushi LH, Byers T, et al: Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin 56:323-353, 2006
4. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
5. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
6. Grothey A, Sargent D, Goldberg RM, et al: Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22:1209-1214, 2004 (Pubitemid 41079833)
7. Mike S, Harrison C, Coles B, et al: Chemotherapy for hormone-refractory prostate cancer. Cochrane Database Syst Rev 18:CD005247, 2006
8. Wei EK, Giovannucci E, Wu K, et al: Comparison of risk factors for colon and rectal cancer. Int J Cancer 108:433-442, 2004 (Pubitemid 37549610)
9. Wolin KY, Yan Y, Colditz GA, et al: Physical activity and colon cancer prevention: A meta-analysis. Br J Cancer 100:611-616, 2009
10. Samad AK, Taylor RS, Marshall T, et al: A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7:204-213, 2005 (Pubitemid 40637417)
11. Haydon AM, Macinnis RJ, English DR, et al: Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55:62-67, 2006 (Pubitemid 41820637)
12. Haydon AM, Macinnis RJ, English DR, et al: Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut 55:689-694, 2006
13. Meyerhardt JA, Giovannucci EL, Holmes MD, et al: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24:3527-3534, 2006 (Pubitemid 46630522)
14. Meyerhardt JA, Giovannucci EL, Ogino S, et al: Physical activity and male colorectal cancer survival. Arch Intern Med 169:2102-2108, 2009
15. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Clin Oncol 24:3535-3541, 2006 (Pubitemid 46630523)
16. Courneya KS, Booth CM, Gill S, et al: The Colon Health and Life-Long Exercise Change trial: A randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol 15:271-278, 2008
17. Blanchard CM, Courneya KS, Stein K: Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the American Cancer Society's SCS-II. J Clin Oncol 26:2198-2204, 2008
18. Courneya KS, Friedenreich CM: Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med 3:215-226, 1997 (Pubitemid 127531542)
19. Courneya KS, Friedenreich CM: Physical exercise and quality of life following cancer diagnosis: A literature review. Ann Behav Med 21:171-179, 1999 (Pubitemid 29445396)
20. Johnson BL, Trentham-Dietz A, Koltyn KF, et al: Physical activity and function in older, long-term colorectal cancer survivors. Cancer Causes Control 20:775-784, 2009
21. Lynch BM, Cerin E, Owen N, et al: Associations of leisure-time physical activity with quality of life in a large, population-based sample of colorectal cancer survivors. Cancer Causes Control 18:735-742, 2007 (Pubitemid 46988241)
22. Peddle CJ, Au HJ, Courneya KS: Associations between exercise, quality of life, and fatigue in colorectal cancer survivors. Dis Colon Rectum 51:1242-1248, 2008
23. Courneya KS, Friedenreich CM, Quinney HA, et al: A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care (Engl) 12:347-357, 2003 (Pubitemid 37550287)
24. Giovannucci E: Diet, body weight, and colorectal cancer: A summary of the epidemiologic evidence. J Womens Health (Larchmt) 12:173-182, 2003
25. Tartter PI, Slater G, Papatestas AE, et al: Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence J Surg Oncol 27:232-235, 1984
26. Meyerhardt JA, Catalano PJ, Haller DG, et al: Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484-495, 2003 (Pubitemid 36885987)
27. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al: Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: Findings from Intergroup trial 0114. J Clin Oncol 22:648-657, 2004 (Pubitemid 41095068)
28. Dignam JJ, Polite BN, Yothers G, et al: Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98:1647-1654, 2006 (Pubitemid 44811647)
29. Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: Findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26:4109-4115, 2008
30. Moon HG, Ju YT, Jeong CY, et al: Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918-1922, 2008
31. Slattery ML, French TK, Egger MJ, et al: Diet and survival of patients with colon cancer in Utah: Is there an association? Int J Epidemiol 18:792-797, 1989 (Pubitemid 20030191)
32. Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 298:754-764, 2007 (Pubitemid 47263158)
33. Dray X, Boutron-Ruault MC, Bertrais S, et al: Influence of dietary factors on colorectal cancer survival. Gut 52:868-873, 2003 (Pubitemid 36613495)
34. Siddiqui SA, Inman BA, Sengupta S, et al: Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 107:521-529, 2006 (Pubitemid 44107212)
35. Davies BJ, Smaldone MC, Sadetsky N, et al: The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol 182:112-117, 2009; discussion 182:117, 2009
36. Giovannucci E, Liu Y, Platz EA, et al: Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121:1571-1578, 2007 (Pubitemid 47328718)
37. Littman AJ, White E, Kristal AR: Anthropometrics and prostate cancer risk. Am J Epidemiol 165:1271-1279, 2007 (Pubitemid 47234324)
38. MacInnis RJ, English DR: Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis. Cancer Causes Control 17:989-1003, 2006 (Pubitemid 44290764)
39. Rodriguez C, Freedland SJ, Deka A, et al: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16:63-69, 2007 (Pubitemid 46174265)
40. Wright ME, Chang SC, Schatzkin A, et al: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109:675-684, 2007 (Pubitemid 46233228)
41. Banez LL, Hamilton RJ, Partin AW, et al: Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 298:2275-2280, 2007 (Pubitemid 350146217)
42. Freedland SJ, Sun L, Kane CJ, et al: Obesity and oncological outcome after radical prostatectomy: Impact of prostate-specific antigen-based prostate cancer screening: Results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 102:969-974, 2008
43. Loeb S, Yu X, Nadler RB, et al: Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 177:102-106, 2007; discussion 177:106, 2007
44. Amling CL, Riffenburgh RH, Sun L, et al: Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22:439-445, 2004 (Pubitemid 41079772)
45. Bassett WW, Cooperberg MR, Sadetsky N, et al: Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSURE. Urology 66:1060-1065, 2005 (Pubitemid 41587161)
46. Efstathiou JA, Bae K, Shipley WU, et al: Obesity and mortality in men with locally advanced prostate cancer: Analysis of RTOG 85-31. Cancer 110:2691-2699, 2007 (Pubitemid 350250338)
47. Freedland SJ, Aronson WJ, Kane CJ, et al: Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22:446-453, 2004 (Pubitemid 41079773)
48. Mallah KN, DiBlasio CJ, Rhee AC, et al: Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 103:2030-2034, 2005 (Pubitemid 40605109)
49. Strom SS, Kamat AM, Gruschkus SK, et al: Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107:631-639, 2006 (Pubitemid 44107225)
50. Strom SS, Wang X, Pettaway CA, et al: Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 11:6889-6894, 2005 (Pubitemid 41428745)
51. Stroup SP, Cullen J, Auge BK, et al: Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Cancer 110:1003-1009, 2007
52. Chun FK, Briganti A, Graefen M, et al: Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. Eur J Cancer 43:375-382, 2007 (Pubitemid 46123989)
53. Gallina A, Karakiewicz PI, Hutterer GC, et al: Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int J Cancer 121:791-795, 2007 (Pubitemid 47106208)
54. Gong Z, Agalliu I, Lin DW, et al: Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 109:1192-1202, 2007 (Pubitemid 46435400)
55. Palma D, Pickles T, Tyldesley S: Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int 100:315-319, 2007 (Pubitemid 47036558)
56. Merrick GS, Galbreath RW, Butler WM, et al: Obesity is not predictive of overall survival following permanent prostate brachytherapy. Am J Clin Oncol 30:588-596, 2007 (Pubitemid 350307183)
57. Smith MR, Bae K, Efstathiou JA, et al: Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. J Clin Oncol 26:4333-4339, 2008
58. Ma J, Li H, Giovannucci E, et al: Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: A long-term survival analysis. Lancet Oncol 9:1039-1047, 2008
59. Smith MR: Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 63:742-745, 2004
60. Smith MR, Finkelstein JS, McGovern FJ, et al: Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87:599-603, 2002 (Pubitemid 34158224)
61. Smith JC, Bennett S, Evans LM, et al: The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86:4261-4267, 2001 (Pubitemid 32848544)
62. Keating NL, O'Malley AJ, Smith MR: Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24:4448-4456, 2006 (Pubitemid 46630983)
63. D'Amico AV, Denham JW, Crook J, et al: Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25:2420-2425, 2007 (Pubitemid 46999213)
64. Shahani S, Braga-Basaria M, Basaria S: Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab 93:2042-2049, 2008 (Pubitemid 351831513)
65. Basaria S, Muller DC, Carducci MA, et al: Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106:581-588, 2006 (Pubitemid 43157621)
66. Dockery F, Bulpitt CJ, Agarwal S, et al: Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci (Lond) 104:195-201, 2003 (Pubitemid 36238052)
67. Cooperberg MR, Grossfeld GD, Lubeck DP, et al: National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst 95:981-989, 2003 (Pubitemid 36896715)
68. Shahinian VB, Kuo YF, Freeman JL, et al: Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer 103:1615-1624, 2005 (Pubitemid 40490022)
69. Johnsen NF, Tjonneland A, Thomsen BL, et al: Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 125:902-908, 2009
70. World Cancer Res Fund/American Institute for Cancer Res: Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington DC, AICR, 2007
71. Thorsen L, Courneya KS, Stevinson C, et al: A systematic review of physical activity in prostate cancer survivors: Outcomes, prevalence, and determinants. Support Care Cancer 16:987-997, 2008
72. Segal RJ, Reid RD, Courneya KS, et al: Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27:344-351, 2009
73. Kenfield SA, Chang ST, Chan JM: Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol 8:173-196, 2007
74. Berkow SE, Barnard ND, Saxe GA, et al: Diet and survival after prostate cancer diagnosis. Nutr Rev 65:391-403, 2007 (Pubitemid 351804347)
75. Demark-Wahnefried W: Dietary interventions in prostate cancer. Curr Urol Rep 9:217-225, 2008
76. Ma RW, Chapman K: A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet 22:187-199, 2009
77. Van Patten CL, de Boer JG, Tomlinson Guns ES: Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: A review of the randomized controlled trial evidence. J Urol 180:2314-2321, 2008; discussion 180:2721-2722, 2008
78. Meyer F, Bairati I, Shadmani R, et al: Dietary fat and prostate cancer survival. Cancer Causes Control 10:245-251, 1999 (Pubitemid 29358957)
79. Strom SS, Yamamura Y, Forman MR, et al: Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer 122:2581-2585, 2008 (Pubitemid 351590493)
80. Ornish D, Weidner G, Fair WR, et al: Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174:1065-1069, 2005; discussion 174:1069-1070, 2005
81. Frattaroli J, Weidner G, Dnistrian AM, et al: Clinical events in prostate cancer lifestyle trial: Results from two years of follow-up. Urology 72:1319-1323, 2008
82. Sandhu MS, Dunger DB, Giovannucci EL: Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94:972-980, 2002 (Pubitemid 34814726)
83. Wolpin BM, Meyerhardt JA, Chan AT, et al: Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27:176-185, 2009